Anzeige
++++++ Spezial am Donnerstag – Neuer Anstoß, News und was die Börsencommunity jetzt nicht verpassen will… ++++++

Assertio Therapeutics WKN: A2N4B9 ISIN: US04545L1070 Kürzel: ASRT Branche:

ASSERTIO THERAPEUTICS Aktie • Kurs heute
0,745 EUR
+2,05 %+0,015
20. Mai 2020, Lang & Schwarz
k.A. % HL Intervall: k.A. High: k.A. Low: k.A. Börse: k.A.
k.A. % HL Intervall: k.A. High: k.A. Low: k.A. Börse: k.A.
k.A. % HL Intervall: k.A. High: k.A. Low: k.A. Börse: k.A.
k.A. % HL Intervall: k.A. High: k.A. Low: k.A. Börse: k.A.
k.A. % HL Intervall: k.A. High: k.A. Low: k.A. Börse: k.A.
k.A. % HL Intervall: k.A. High: k.A. Low: k.A. Börse: k.A.
k.A. % HL Intervall: k.A. High: k.A. Low: k.A. Börse: k.A.
k.A. % HL Intervall: k.A. High: k.A. Low: k.A. Börse: k.A.
Anzeige
Smartbroker entdecken
Jetzt Smartbroker
Smartbrokerplus
Themen entdecken
Chemical
Chemical, DEPOMED Hauptdiskussion, 11.05.2020 14:44 Uhr
Assertio Therapeutics EPS beats by $0.18, beats on revenue https://seekingalpha.com/news/3572647-assertio-therapeutics-eps-beats-0_18-beats-on-revenue
Chemical
Chemical, DEPOMED Hauptdiskussion, 15.02.2020 8:29 Uhr
Assertio Therapeutics: A Biotech Stock Trading Below Its Cash Balance https://seekingalpha.com/article/4324469-assertio-therapeutics-biotech-stock-trading-below-cash-balance Takeaway ASRT has seen its fair share of woes, from the recent rejection of its cosyntropin sNDA, to below-average data readout on collaboration project IW-3718, and to a staggering -20% Y/Y decline on core product revenues. On the other hand, the recent sale of Nucynta for $375M removes all remaining debt from the company's balance sheet, causes its stock to trade at negative enterprise value, and adds sizable capital for future R&D efforts. Keep in mind, ASRT is estimated to continue its profitability after the deal closes, as its remaining products have over 60-80% gross margin. Hence, the author finds the benefit to outweigh the company's drawbacks, and will reiterate the company's buy rating as of today.
Andymac0815
Andymac0815, DEPOMED Hauptdiskussion, 06.02.2020 23:08 Uhr
Letztes Jahr mit Verlust raus 🤤
Chemical
Chemical, DEPOMED Hauptdiskussion, 06.02.2020 22:04 Uhr
Assertio Therapeutics Announces Sale of NUCYNTA® Franchise to Collegium Pharmaceutical for $375.0 Million https://newsfilter.io/a/3d0fa5d5f5e45ad603002142755aedb8
Billi1
Billi1, DEPOMED Hauptdiskussion, 13.01.2020 15:43 Uhr
😎
Chemical
Chemical, DEPOMED Hauptdiskussion, 13.01.2020 14:21 Uhr
👀
Chemical
Chemical, DEPOMED Hauptdiskussion, 13.01.2020 14:20 Uhr
Assertio Therapeutics Sees FY19 Neurology Franchise Sales Above Guidance Range Of $102M-$105M
Chemical
Chemical, DEPOMED Hauptdiskussion, 13.01.2020 14:19 Uhr
Assertio Therapeutics Announces Closing Of Gralise Sale To Alvogen; Co. To Receive $127.5M
Chemical
Chemical, DEPOMED Hauptdiskussion, 28.12.2019 14:28 Uhr
Assertio pipeline products https://www.assertiotx.com/products-and-pipeline/pipeline/ Zwei Medikamente stehen vor dem Approvel
Chemical
Chemical, DEPOMED Hauptdiskussion, 27.12.2019 20:28 Uhr
Assertio (ASRT) Upgraded to Strong Buy: What Does It Mean for the Stock? https://finance.yahoo.com/news/assertio-asrt-upgraded-strong-buy-170005299.html The upgrade of Assertio to a Zacks Rank #1 positions it in the top 5% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term.
Chemical
Chemical, DEPOMED Hauptdiskussion, 27.12.2019 20:26 Uhr
ASRT vs. PCRX: Which Stock Is the Better Value Option? https://finance.yahoo.com/news/asrt-vs-pcrx-stock-better-164004569.html ASRT sticks out from PCRX in both our Zacks Rank and Style Scores models, so value investors will likely feel that ASRT is the better option right now
FCINGO
FCINGO, DEPOMED Hauptdiskussion, 27.12.2019 14:15 Uhr
Karmate, was erwartet du hier ?
Karmate1
Karmate1, DEPOMED Hauptdiskussion, 26.12.2019 13:48 Uhr
Es geht los
Karmate1
Karmate1, DEPOMED Hauptdiskussion, 26.12.2019 13:47 Uhr
🚀
rationality
rationality, DEPOMED Hauptdiskussion, 13.12.2019 15:38 Uhr
Ich leider auch...
Themen zum Wert
1 DEPOMED Hauptdiskussion
Kursdetails
Geld (bid) 0,735 (6.854)
Brief (ask/offer) 0,755 (6.854)
Spread 2,649
Geh. Stück 0
Eröffnung 0,730
Vortag 0,730
Tageshoch 0,745
Tagestief 0,730
52W Hoch 0,000
52W Tief 0,000
Tagesvolumen
in USD gehandelt 1,1 Mio. Stk
Gesamt 1,1 Mio. Stk
Partner-News
Anzeige

16:46 Uhr • Partner • Societe Generale

16:00 Uhr • Partner • BNP Paribas

14:35 Uhr • Partner • Societe Generale

14:20 Uhr • Partner • BNP Paribas

Aktien-News
Geld/Brief Kurse
Neu laden
Börse Geld Vol. Brief Vol. Zeit Vol. ges. Kurs
Nasdaq 0,791 3.400 Stk 0,802 2.400 Stk 1589940000 20. May 1,1 Mio. Stk 0,796 USD
ges. 1.143.184 Stk
Realtime / Verzögert
Börsennotierung
Marktkapitalisierung in EUR
59,4 Mio.
Anzahl der Aktien
81,4 Mio.
BörseNEWS.de Community. Sei dabei.